Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Patients with Moderate-to-Severe Atopic Dermatitis Mainta... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment
0
Authors
Jonathan Silverberg
13 more
Jonathan Silverberg
•
Andreas Wollenberg
11 more
•
Sonja Ständer
Published
August 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Dermatology and Therapy
Topics
Medicine
Dermatology
Rheumatology
Immunology And Allergy
Atopic Dermatitis
DOI
10.1007/s13555-024-01226-9
License
CC-BY-NC
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Dermatology and Therapy
Topics
Medicine
Dermatology
Rheumatology
Immunology And Allergy
Atopic Dermatitis
DOI
10.1007/s13555-024-01226-9
License
CC-BY-NC
